Elevated glucose, metabolic syndrome and diabetes predict lower treatment response to triple therapy with telaprevir in HCV
Elmar Jaeckel,Christine John,Renate Heyne,Gerlinde Teuber, Willi Schiffelholz,Stefan Christensen,Christoph Antoni,Stefan Pape,Martin Roessle, Hanns-Friedrich F. Loehr,Klaus H. Boeker,Andreas Schober,Thomas Lutz,Harald-Robert Bruch,Stefan Mauss,Hermann Steffens,Ulrich Alshuth,Michael P. Manns HEPATOLOGY（2013）
AI 理解论文
溯源树
样例
